Year archive

Jagsonpal Pharmaceuticals Limited — 2024 filings

All 180 regulatory filings released by Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) in 2024, sourced directly from the official regulator.

180 Filings

2024 Period

2024 filings (180)

Filing	Released	Lang
Trading Window Regulatory Filings	2024-12-30	English
In terms of SEBI (Prohibition of Insider Trading) Regulation, 2015 the trading window for dealing in securities of Jagsonpal Pharmaceuticals Limited shall remain closed for Designated persons .... Regulatory Filings	2024-12-30	English
Record Date Share Issue/Capital Change	2024-12-17	English
In terms of Reg. 42 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015 the Company has fixed record date as January 08, 2025 for sub division/Split of face value .... Regulatory Filings	2024-12-17	English
Shareholders meeting Regulatory Filings	2024-12-12	English
0Dear Sir/Madam, In continuation to our letter dated November 11, 2024, please find enclosed the following: Voting results under Reg. 44 of SEBI (LODR) Reg. 2015 along with Scrutinizer report Regulatory Filings	2024-12-12	English
Updates Share Issue/Capital Change	2024-12-06	English
Pursuant to SEBI (LODR) Reg. 2015 as amended we are pleased to inform you that Nomination and Remuneration Committee has issued and alloted 31,040 Equity Shares of Rs. 5/- under JPL ESOP 2022. Regulatory Filings	2024-12-06	English
Updates Board/Management Information	2024-11-22	English
We wish to inform you that Mr. Ashish Lakhotia has submitted the resignation as Chief Financial Officer of the Company & Key Managerial Personnel of the Company to pursue the opportunities .... Regulatory Filings	2024-11-22	English
In furtherance to our intimation dated November 03, 2023 and July 25, 2024, please find enclosed herewith update on Sale of Company''s Faridabad Facility. Regulatory Filings	2024-11-19	English
Updates Capital/Financing Update	2024-11-19	English
In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed details of meeting attended by the Company with Analyst/Institutional Investor. Regulatory Filings	2024-11-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-11-12	English
We wish to inform you that the Company is proposing to participate in the Analysts/Institutional Investors Meeting on November 18, 2024. Regulatory Filings	2024-11-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-11-12	English
Please find enclosed copies of the newspaper publication regarding completion of dispatch of Postal Ballot Notice of the Company. Regulatory Filings	2024-11-12	English
Copy of Newspaper Publication Regulatory Filings	2024-11-12	English
Shareholders meeting Proxy Solicitation & Information Statement	2024-11-11	English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed postal notice for ordinary and special resolutions to approve .... Regulatory Filings	2024-11-11	English
General Updates Share Issue/Capital Change	2024-11-05	English
Pursuant to SEBI (LODR) Reg. 2015, we are pleased to inform you that NRC is issued and alloted 30,311 shares of Rs. 5 each to eligible employees of the Company pursuant to excercise of ESOP options. Regulatory Filings	2024-11-05	English
In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed meeting attended by the Company with Analyst/Institutional Investor. Regulatory Filings	2024-11-04	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-11-04	English
In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed meeting attended by the Company with Analyst/Institutional Investor. Regulatory Filings	2024-11-04	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-11-04	English
Please find enclosed Transcript for the Jagsonpal Pharmaceuticals Limited Q2FY25 Earning Confrence Call held on October 24, 2024 at 11:00 AM for discussion of Q2FY25 & H1FY25 Financial Results. Regulatory Filings	2024-10-29	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2024-10-29	English
Pursuant to the provision of Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement publisher on October .... Regulatory Filings	2024-10-25	English
Copy of Newspaper Publication Regulatory Filings	2024-10-25	English
Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY25 and H1 FY25 Earnings Conference Call on October 24, 2024 Regulatory Filings	2024-10-24	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2024-10-24	English
General Updates Investor Presentation	2024-10-24	English
In continuation to earlier intimation dated October 23, 2024 Please find enclosed herewith revised investor presentation for quarter and half year ended September 30, 2024 due to inadvertent .... Regulatory Filings	2024-10-24	English
Related Party Transactions Regulatory Filings	2024-10-23	English
Please find enclosed related party transaction for half year ended September 30, 2024 Regulatory Filings	2024-10-23	English
Amendment to AOA/MOA Capital/Financing Update	2024-10-23	English
Please note that pursunat to split of shares there is change in authorised share capital clause of MOA and AOA Regulatory Filings	2024-10-23	English
Please find enclosed intimation for split of shares from face value of Rs. 5 to Rs.2 Regulatory Filings	2024-10-23	English
Press Release Interim / Quarterly Report	2024-10-23	English
Please find enclosed press release and investor presentation for quarter and half year ended September 30, 2024. Regulatory Filings	2024-10-23	English
Financial Result Updates Regulatory Filings	2024-10-23	English
Please find enclosed Unaudited financial result and limited review report for quarter and half year ended September 30, 2024 Regulatory Filings	2024-10-23	English
Stock split Regulatory Filings	2024-10-23	English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... Regulatory Filings	2024-10-23	English
In Compliance with Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer .... Regulatory Filings	2024-10-16	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,we wish to inform you that the Company, as a .... Regulatory Filings	2024-10-16	English
Board Meeting — JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Co… Regulatory Filings	2024-10-16	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-10-16	English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 ,inter alia, to consider and approve (i) Unaudited Financial .... Regulatory Filings	2024-10-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2024-10-16	English
Board Meeting — Financial Results/Stock Split Regulatory Filings	2024-10-16	English
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(iii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... Regulatory Filings	2024-10-14	English
Action(s) taken or orders passed Regulatory Filings	2024-10-12	English
Please find enclosed intimation for receipt of Settlement Order from the Securities and Exchange Board of India in respect of settlement application filed by Mr. Rajpal Singh Kochhar, one .... Regulatory Filings	2024-10-12	English
Trading Window Regulatory Filings	2024-09-27	English
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & their immediate relatives, .... Regulatory Filings	2024-09-27	English
Updates Share Issue/Capital Change	2024-09-26	English
Pursuant to SEBI (LODR) Reg. 2015 as amended, we are pleased to inform you that Nomination and Remuneration Committee has issued and alloted 27,500 equity shares of Rs. 5 Each to eligible .... Regulatory Filings	2024-09-26	English
Shareholders meeting Regulatory Filings	2024-09-19	English
Please find enclosed herewith Voting results and Scrunitizer results of 45th Annual General meeting held on September 18, 2024 at 03:30 p.m. Regulatory Filings	2024-09-19	English
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith summary of Proceedings of the 45th AGM of the Company .... Regulatory Filings	2024-09-18	English
Shareholders meeting AGM Information	2024-09-18	English
Please find enclosed herewith disclosure under Regulation 7(1) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Regulatory Filings	2024-09-18	English
Updates Major Shareholding Notification	2024-09-18	English
Please find enclosed the schedule of Analysts/Institutional Investors Meeting. Regulatory Filings	2024-09-18	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-09-18	English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Portfolio Holdings Regulatory Filings	2024-09-18	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Holdings & Others Regulatory Filings	2024-09-18	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Portfolio Holdings & PACs Regulatory Filings	2024-09-18	English
Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2024-09-17	English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... Regulatory Filings	2024-09-06	English
Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2024-09-05	English
Updates Board/Management Information	2024-09-03	English
we would like to inform the exchange that Company has appointed M/s. Go India Advisors LLP as its Investor Relationship Agency for providing Investor Relation Advisory services to the Company. Regulatory Filings	2024-09-03	English
In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed copies of newspaper publication post dispatch of annual report. Regulatory Filings	2024-08-28	English
Copy of Newspaper Publication Regulatory Filings	2024-08-28	English
Shareholders meeting Annual Report	2024-08-27	English
Notice of 45th Annual General Meeting of the Company and Annual Report for FY 23-24. The AGM of the Company will be held on Wednesday, September 18, 2024 at 03:30 p.m. through Audio Visual/Other .... Regulatory Filings	2024-08-27	English
Pursuant to Regulation 34(2)(f) of the SEBI (Listing and Obligations & Disclosure Requirements) Regulations, 2015, Please find enclosed Business Responsibility and Sustainability Reporting .... Regulatory Filings	2024-08-27	English
Pursuant to Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the Annual Report and Notice .... Regulatory Filings	2024-08-27	English
In terms of regulation 30 of SEBI (LODR) Regulation, 2015, Please find enclosed copies of the newspaper publication for 45th AGM of the Company to be held through Video Conferencing (VC)/ .... Regulatory Filings	2024-08-23	English
Copy of Newspaper Publication AGM Information	2024-08-23	English
Loss of Share Certificates Regulatory Filings	2024-08-10	English
Please find enclosed details pertaining to letter of confirmation issued by the Company to its shareholders in lieu of Duplicate Share Certificates Regulatory Filings	2024-08-10	English
Record Date AGM Information	2024-08-07	English
This is to inform you that the 45th Annual General Meeting (the ''AGM'') of the Members of the Company will be held on Wednesday, September 18, 2024 at 03:30 p.m. (IST) through OAVM. Company .... Regulatory Filings	2024-08-07	English
ESOP/ESOS/ESPS Capital/Financing Update	2024-08-07	English
We wish to inform you that the Nomination and Remuneration Committee of Board of Directors at their meeting held on August 07, 2024 approved the grant of 68,000 employees stock option under .... Regulatory Filings	2024-08-07	English
Please find enclosed herewith press release and investor presentation for Unaudited Financial result for quarter ended June 30, 2024 Regulatory Filings	2024-08-07	English
Press Release Interim / Quarterly Report	2024-08-07	English
Please find enclosed herewith Unaudited Financial Results along with limited review report for quarter ended June 30, 2024. Regulatory Filings	2024-08-07	English
Financial Result Updates Regulatory Filings	2024-08-07	English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... Regulatory Filings	2024-08-07	English
Outcome of Board Meeting Regulatory Filings	2024-08-07	English
Press Release Regulatory Filings	2024-08-05	English
In terms of Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed copy of press release issued by Company titled "Jagsonpal''s CSR Initiative - MySakhi strengthens its Women''s .... Regulatory Filings	2024-08-05	English
Please find enclosed details received regarding issue of duplicate of share certificate of shareholder from our registrar and share transfer agent - MCS Share Transfer Agent Limited Regulatory Filings	2024-08-02	English
Loss of Share Certificates Regulatory Filings	2024-08-02	English
Board Meeting — JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Com… Regulatory Filings	2024-07-31	English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 ,inter alia, to consider and approve the Unaudited Financial .... Regulatory Filings	2024-07-31	English
Board Meeting — Financial Results Regulatory Filings	2024-07-31	English
Updates Capital/Financing Update	2024-07-25	English
Further, to our intimation dated November 03, 2023 on the proposed divestment of Company''s Faridabad facility. We now wish to inform you that the Company has entered into an Agreement .... Regulatory Filings	2024-07-25	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-07-17	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer Agent .... Regulatory Filings	2024-07-17	English
Trading Window Regulatory Filings	2024-06-28	English
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & Immediate relative of .... Regulatory Filings	2024-06-28	English
We are Pleased to informed you that the Nomination and Remuneration Committee has issued and allotted 16,317 Equity shares of Rs. 5/- each under JPL ESOP 2022, to the eligible employee .... Regulatory Filings	2024-06-20	English
ESOP/ESOS/ESPS Capital/Financing Update	2024-06-20	English
Acquisition Regulatory Filings	2024-05-31	English
We now wish to inform you that on completion of customary conditions, the transactions has now achieved as closure. Regulatory Filings	2024-05-31	English
Please find enclosed herewith copy of press release isuued by the company titled " Jagsonpal Launched MemUp: India''s First Biodentical Hormone Replacement Therapy in a Single Pill" Regulatory Filings	2024-05-24	English
Press Release Regulatory Filings	2024-05-24	English
Please find enclosed copies of advertisement published on May 22, 2024, in ''Business Standard'' (English) and ''Business Standard'' (Hindi) newspaper providing Extract of Audited Financial .... Regulatory Filings	2024-05-22	English
Copy of Newspaper Publication Regulatory Filings	2024-05-22	English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annual Secretarial Compliance Report for the Financial Year .... Regulatory Filings	2024-05-21	English
Related Party Transactions Regulatory Filings	2024-05-20	English
Please find enclosed related party disclosure for the half year ended October 01, 2023 to March 31, 2024 Regulatory Filings	2024-05-20	English
ESOP/ESOS/ESPS Regulatory Filings	2024-05-20	English
Intimation of grant of Employee Stock Options Regulatory Filings	2024-05-20	English
Dividend Updates Regulatory Filings	2024-05-20	English
The Board of Directors at their meeting held today have recommended dividend of Rs. 5/- (100%) per equity share of face value of Rs. 5/- for the financial year ended March 31, 2024. Regulatory Filings	2024-05-20	English
Please find enclosed press release and Investor Deck for the quarter and year ended March 31, 2024 Regulatory Filings	2024-05-20	English
Press Release Regulatory Filings	2024-05-20	English
Please find enclosed Audited Financial Result for the year ended March 31, 2024 along with Indepedent Auditors Report Regulatory Filings	2024-05-20	English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... Regulatory Filings	2024-05-20	English
Financial Result Updates Regulatory Filings	2024-05-20	English
Dividend Regulatory Filings	2024-05-20	English
Acquisition Capital/Financing Update	2024-05-16	English
We wish to inform you that Jagsonpal Pharmaceuticals Limited (''the Company'') has signed the Business Transfer Agreement ("BTA") for the purchase of India and Bhutan business of Yash Pharma .... Regulatory Filings	2024-05-16	English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve the Audited Financial .... Regulatory Filings	2024-05-13	English
Board Meeting — JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2024 to consider and approve the Yearly Audited Financial results of the Company f… Regulatory Filings	2024-05-13	English
Board Meeting — Financial Results/Dividend Regulatory Filings	2024-05-13	English
Press Release Regulatory Filings	2024-05-10	English
In term of Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the press release issued by the company titled " JAGSONPAL LAUNCHES WOMEN''S HEALTH .... Regulatory Filings	2024-05-10	English
Loss of Share Certificates Regulatory Filings	2024-05-07	English
Intimation for issuance of Letter of Confirmation under SEBI LODR Regulations, 2015 Regulatory Filings	2024-05-07	English
Pursuant to SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and .... Regulatory Filings	2024-05-04	English
ESOP/ESOS/ESPS Regulatory Filings	2024-05-04	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2024-05-03	English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... Regulatory Filings	2024-04-29	English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2024-04-29	English
We hereby submit a certificate from Practising Company Secretary under Reg. 40(9) of SEBI (LODR) Reg. 2015 for the year ended March 31, 2024. Regulatory Filings	2024-04-25	English
Loss of Share Certificates Regulatory Filings	2024-04-12	English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details received regarding issue of duplicate .... Regulatory Filings	2024-04-12	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-04-02	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer Agent .... Regulatory Filings	2024-04-02	English
Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate jointly .... Regulatory Filings	2024-04-02	English
Trading Window Regulatory Filings	2024-03-29	English
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of .... Regulatory Filings	2024-03-29	English
ESOP/ESOS/ESPS Regulatory Filings	2024-03-29	English
Pursuant to SEBI ( Listing Obligations and Disclosure Requirements), 2015, as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and allotted .... Regulatory Filings	2024-03-29	English
In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Press Release issued by the Company titled ''Jagsonpal Pharmaceuticals launches QueeZy-ER. Regulatory Filings	2024-03-08	English
Press Release Regulatory Filings	2024-03-08	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-03-07	English
We wish to inform you that the Company is participating in the ''Systematix Group -Pharma & Healthcare Day' scheduled to be held on Wednesday, March 13, 2024 where the Company will be interacting .... Regulatory Filings	2024-03-07	English
Loss of Share Certificates Regulatory Filings	2024-02-20	English
Issuance of Letter of Confirmation in lieu of Duplicate Share Certificate Regulatory Filings	2024-02-20	English
Loss of Share Certificates Regulatory Filings	2024-02-05	English
Please find enclosed herewith details regarding loss of duplicate share certificate of shareholders from our RTA - MCS Share Transfer Agent Limited. Regulatory Filings	2024-02-05	English
Copy of Newspaper Publication Regulatory Filings	2024-02-03	English
Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Newspaper advertisement published .... Regulatory Filings	2024-02-03	English
Updates Regulatory Filings	2024-02-02	English
We wish to inform you that consequent to the appointment of Mr. Ashish Lakhotia, Chief Financial Officer of the Company, the Board of Directors have approved the Change in KMPs for authorised .... Regulatory Filings	2024-02-02	English
Change in Management Regulatory Filings	2024-02-02	English
Please find enclosed the intimation on change in Key Managerial Personnel. Regulatory Filings	2024-02-02	English
Press release for the quarter and nine months ended December 31, 2023. Regulatory Filings	2024-02-02	English
Press Release Regulatory Filings	2024-02-02	English
Financial Result Updates Regulatory Filings	2024-02-02	English
Please find enclosed Unaudited Financial Results for Quarter and Nine Months ended December 31, 2023 along with limited review report for the quarter and nine months ended December 31, 2023. Regulatory Filings	2024-02-02	English
Outcome of Board Meeting Regulatory Filings	2024-02-02	English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... Regulatory Filings	2024-02-02	English
Board Meeting — JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Com… Regulatory Filings	2024-01-25	English
Board Meeting — Financial Results Regulatory Filings	2024-01-25	English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 ,inter alia, to consider and approve Unaudited Financial .... Regulatory Filings	2024-01-25	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-01-19	English
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 we are enclosing herewith a copy of the certificate received from M/S MCS Share Transfer Agent .... Regulatory Filings	2024-01-19	English
ESOP/ESOS/ESPS Regulatory Filings	2024-01-04	English
Pursuant to SEBI LODR Regulations, 2015 as amended, we are pleased to inform you that the Nomination and Reumneration Committee has issued and alloted 50,000 Equity Shares of Rs. 5/- Each .... Regulatory Filings	2024-01-04	English

Filings by year

2026 88 filings
2025 182 filings
2024 180 filings
2023 104 filings
2022 129 filings
2021 89 filings
2020 79 filings
2019 71 filings
2018 22 filings
2017 32 filings
2016 28 filings
2015 14 filings
2014 7 filings
2013 7 filings
2012 4 filings
2011 4 filings
2010 1 filing